Although the genotoxic mechanism(s) of hexavalent chromium (CrVI) carcinogenicity remain to be fully elucidated, intracellular reduction of CrVI and concomitant generation of reactive intermediates including reactive oxygen species and subsequent oxidative damage to DNA is believed to contribute to the process of carcinogenesis. In the current study, substantial interindividual variation (7.19-25.84% and 8.79-34.72% tail DNA as assessed by conventional and FPGmodified comet assay, respectively) in levels of DNA strand breaks after in vitro treatment of WBC with sodium dichromate (100 Amol/L, 1 hour) was shown within a group of healthy adult volunteers (n = 72) as assessed by both comet and formamidopyrimidine glycosylase -modified comet assays. No statistically significant correlation between glutathione S-transferases M1 or T1, NADPH quinone oxidoreductase 1 (codon 187) and X-ray repair cross complementation factor 1 (codon 194) genotypes and individual levels of DNA damage were observed. 
Introduction
Epidemiologic studies, supported by animal and in vitro data, suggest that hexavalent chromium (CrVI) compounds are carcinogenic, and the IARC has classified CrVI as a group I carcinogen (1) . CrVI compounds are used industrially as catalysts, corrosion inhibitors, and as alloying metal for making stainless steel and various superalloys. Subsequently, CrVI is present in various welding fumes (2) (3) (4) (5) . In the workplace, exposure to chromium can be oral and dermal; however, the respiratory tract is the major site of exposure and, consequently, there is an increased risk of cancers of the respiratory system in exposed individuals (2) .
CrVI compounds including sodium dichromate are genotoxic and cause DNA strand breaks (6, 7), chromium-DNA adducts (8) , DNA-DNA (9), DNA-protein cross-links (10) , and oxidative base damage including 8-oxo-7,8-dihydro-2V-deoxyguanosine (8-oxo-dG; ref. 6) in vitro. Although the mechanism(s) involved remains to be fully elucidated (2) , intracellular reduction of CrVI by cellular reductants such as reduced glutathione (GSH) and ascorbic acid and the subsequent generation of partially reduced chromium species such as CrV and CrIV are believed to be important (11) . In addition, reduction of CrVI may also result in the concomitant generation of reactive oxygen species including hydroxyl radicals (˙OH), singlet oxygen (O), superoxide (O 2˙) and hydrogen peroxide (12) (13) (14) (15) . In addition to reductive activation of CrVI, the antioxidant nature of GSH may also play a protective role in detoxification of reactive oxygen species and partially reduced chromium species. Interestingly, recent studies have indicated that human lung cells are able to internalize particulate chromium, resulting in high local intracellular concentrations of CrVI whose effects seem to be mediated by reactive oxygen species (16, 17) .
The alkaline version of the single cell gel electrophoresis assay or comet assay represents a sensitive technique for the detection of ssDNA breaks in cells exposed to genotoxic carcinogens. Collins et al. (18) developed the use of formamidopyrimidine glycosylase (FPG) in the comet assay for the specific detection of oxidized purines, predominantly 8-oxodG. Because of its sensitivity, many studies have used the comet assay to investigate CrVI-induced DNA damage in vitro (e.g., 6, [19] [20] [21] [22] [23] [24] .
Biomarkers of susceptibility are indicators of an inherent or acquired limitation of an organism's ability to respond to the challenge of exposure to a specific xenobiotic substance (25) . Examples include interindividual differences in metabolism (activation and detoxification) of carcinogenic chemicals, DNA repair, and the functions of proto-oncogenes or tumor suppressor genes, as well as interindividual differences in nutritional, hormonal, and immunologic factors (26) .
The intracellular reduction of sodium dichromate is extremely complex and involves multiple pathways including metabolism by enzymes for which functional polymorphisms in human populations are known to exist (e.g., NQO1 and cytochrome P450s 27-29). A major defense system against the damaging effects of oxidative stress are the glutathione S-transferases (GST), which catalyze the nucleophilic addition of glutathione (GSH) to electrophilic acceptors including toxic products generated from tissue damage (e.g.,glutathionealkenes, epoxides, hydroperoxides, and aldehydes) produced as a result of lipid peroxidation (30) .
A wide range of low molecular weight cellular antioxidants (e.g., GSH, ascorbic acid, melatonin, and vitamins D and E) also plays a role in the reduction and metabolic activation of CrVI (31, 32) . It is likely that intracellular levels of these molecules will be influenced by both genetic factors and environmental factors including diet, alcohol consumption, and smoking habit. In addition, several components of the base excision repair pathway, including the DNA glycosylase 8-oxo-7,8-dihydro-2V-deoxyguanosine glycosylase 1 (OGG1) and X-ray repair cross complementation 1 (XRCC1), are also polymorphic in the human population. Base excision repair is the principal pathway for repair of oxidative DNA damage including 8-oxo-dG in eukaryotic cells. Therefore, functional polymorphisms in components of the cellular base excision repair machinery may also be expected to influence levels of sodium dichromate -induced oxidative DNA damage.
Because of the above factors, it is likely that there will be a considerable heterogeneity in individual response to sodium dichromate -induced DNA damage. The aim of the current study, therefore, is to utilize the conventional and FPGmodified comet assay to study interindividual differences in DNA damage in human WBC after treatment in vitro with sodium dichromate. The relationship between differences in life-style factors, plasma antioxidant capacity, and genetic polymorphisms in detoxification (GSTM1, GSTT1, NQO1) and DNA repair (OGG1, XRCC1) genes and levels of sodium dichromate -induced DNA damage were investigated in an attempt to identify potential biomarkers of susceptibility to sodium dichromate -induced DNA damage.
Materials and Methods
All chemicals were obtained from (Sigma-Aldrich, Poole, Dorset, United Kingdom) and were the highest purity available unless stated otherwise.
Sample Collection. Ethical approval was granted from South Birmingham, United Kingdom, Local Research Ethics Committee before commencement of the study. Subjects for study were healthy adults ages 17 to 62 years (n = 72). After obtaining their informed consent, blood samples (2 mL) were obtained by venipuncture and collected in Vacutainer tubes (Haemograd, Becton Dickinson, United Kingdom) containing either EDTA or sodium heparin anticoagulant. All samples were stored on ice until required and were processed within 3 hours of sample collection. Volunteers completed a detailed questionnaire at the time of sampling in order to gather information on diet, smoking habit, age, and alcohol consumption.
Comet Assay. The comet assay was done as described by Singh et al. (33) with the following alterations. Whole blood (10 AL; EDTA anticoagulant) was suspended in 1 mL HBSS containing 100 Amol/L sodium dichromate and incubated for 1 hour at 37jC. Although cells respond to lower concentrations of sodium dichromate (34) this concentration was used to provide sufficient sensitivity to discriminate between individual responses. After treatment, cells were pelleted by centrifugation (200 Â g, 5 minutes). Cell pellets were resuspended in 0.5% low-melting-point agarose (110 AL) and transferred to a glass microscope slide (Surgipath, Peterborough, United Kingdom) that had been precoated with 0.5% normal-meltingpoint agarose. The slides were coverslipped and placed on ice for a further 10 minutes. Coverslips were removed and the slides lysed for 1 hour at 4jC in lysis buffer (2.5 mol/L NaCl, 100 mmol/L Na 2 EDTA, 10 mmol/L Tris base, 1% sodium N-lauryl sarcosinate, 10% DMSO, and 1% Triton X-100). Slides were then transferred to a horizontal electrophoresis tank (Pharmacia Biotech, Little Chalfont, Buckinghamshire, United Kingdom) containing electrophoresis buffer (300 mmol/L NaOH, 1 mmol/L EDTA, pH 13). After exactly 20 minutes to allow DNA unwinding, they were subjected to electrophoresis for 20 minutes using an electrophoresis power supply (Pharmacia LKB, Cambridge, United Kingdom). After electrophoresis, slides were neutralized by flooding with three changes of neutralization buffer (0.4 mol/L Tris, pH 7.5) for 5 minutes each wash. The slides were then stained with 50 AL ethidium bromide solution (20 Ag/mL).
FPG-Modified Comet Assay. The modified comet assay was carried out as described by Collins et al. (18) . Briefly, The comet assay was carried out as described above, with the exception that after lysis slides were washed 3 Â 5 minutes with FPG buffer (40 mmol/L HEPES, 0.1 mol/L KCl, 0.5 mmol/L EDTA, 0.2 mg/mL bovine serum albumin, pH 8). After this time, the slides were incubated with 1 unit of FPG enzyme (Trevigen, Gaithersburg, MD) in 50 AL FPG buffer at 37jC for 1 hour. After this time, the slides were incubated with 1 unit FPG enzyme (Trevigen) in 50 mL FPG buffer at 37jC for 1 hour as optimized by Collins et al. (18) . One unit FPG is defined as the amount of enzyme required to cleave 1 pmol 32 P-labeled oligonucleotide probe containing 8-oxo-dG within an oligonucleotide duplex in 1 hour at 37jC. To minimize potential variation in FPG activity, the same batch number (3632LO, stored at À80jC in aliquots) was used in all experiments. Control slides were incubated with 50 AL FPG buffer only. DNA unwinding and electrophoresis were then completed as described above.
Slide Visualization and Analysis. Slides were examined at 320Â magnification (32Â/0.40 dry objective) using a fluorescence microscope (Zeiss, Welwyn Garden City, Hertforshire, United Kingdom), fitted with a 515-to 560-nm excitation filter and a barrier filter of 590 nm. A video camera (Kinetic Pulnix TM-765) received the images, which were analyzed with a personal computer -based image analysis system Komet 3.0 Europe (Kinetic Imaging Ltd., Liverpool, United Kingdom). One hundred randomly selected nuclei were analyzed per slide using the equipment described. We note that our sample numbers are 8 to 30 per group compared with the n = 3 to 5 commonly used in standard testing experiments and our replicates are within the range reported by Duez et al. (35) . Measurements of percent tail DNA were determined to assess the extent of DNA damage. This parameter is the preferred measurement as it is linearly related to the DNA break frequency over a wide range of levels of damage (36) . The unmodified version of the comet assay was carried out in parallel so levels of FPG-dependent oxidative damage (exceeding background levels of DNA strand breaks and labile site) could be determined.
Genotyping Analyses. Genomic DNA was isolated from whole blood (f1 mL) using a QIAamp blood spin column midi kit (Qiagen, Crawley, United Kingdom), according to the manufacturer's instructions. PCR genotyping reactions were carried out as previously reported to detect deletions in GSTM1 and GSTT1 (37) , with the exception that GST and albumin (internal control) primers sequences were as detailed previously (38) . In addition, previously reported RFLP-PCR methods were used to detect polymorphisms in NQO1 at codon 609 (39), OGG1 at codon 326 (40) , and XRCC1 at codon 194 (41) .
Plasma Preparation and Plasma Antioxidant Test. Whole blood (500 AL; heparin anticoagulant) was centrifuged for 15 minutes at 1500 Â g at room temperature. Plasma was stored at À70jC until analysis. Plasma antioxidant capacity was determined by measuring the ability of samples to inhibit superoxide-dependent pholasin fluorescence using a commercially available bioluminescence ABEL kit (Knight Scientific, Plymouth, United Kingdom) according to the manufacturer's instructions. Briefly, bioluminescence was measured using a plate reader luminometer (Tecan Instruments, Reading, Berkshire, United Kingdom) and antioxidant capacity of each individual plasma sample was expressed as the percentage reduction in fluorescence emission compared with a negative control containing no plasma.
Statistical Analyses. All data were analyzed using SPSS version 10 statistical package (SPSS, Working, Surrey, United Kingdom). Differences between both mean and median tail DNA before and after treatment were calculated using a onetailed paired Student's t test as recommended by Duez et al. (35) . In comparison of tail DNA values between individuals, the comet values were log transformed (mean values only) before analysis. If there were two genotypes in the group (GSTM1 and GSTT1) a one-way ANOVA test was used to analyze differences between the mean tail DNA with or without treatment. For NQO1, OGG1 and XRCC1 (three genotypes per group) the one-way ANOVA was accompanied by a post hoc Scheffe test. All correlations between comet tail DNA and plasma antioxidant capacity were determined by Pearson's correlation coefficient test (2-tailed).
Results
We have previously shown that sodium dichromate induces detectable DNA strand breaks at concentrations as low as 100 nmol/L (34), which is relevant to potential human exposure. However, we emphasize that a higher concentration of 100 Amol/L for 1-hour exposure was most appropriate for the current study because of the need to optimize sensitivity in the search for interindividual differences. We were careful to ensure that this concentration did not cause cytotoxicity as assessed by ATP content and frequency of apoptosis over the period investigated (6, 34) .
Characteristics of the Study Population. The mean age of volunteers was 34.8 F 11.3 (SD, n = 72) years. Of the 72 subjects studied, 40 (55.6%) were female and 32 (44.4%) were male. Information gathered from the self-administered questionnaires revealed that 5.6% of the population were vegetarian, 23.6% were smokers, and 86.1% were Caucasian (Table 1) .
A general linear univariate ANOVA model was constructed to identify potential confounding factors. Age, ethnicity, gender, alcohol consumption (in the previous week), cigarettes smoked per day on average, vegetable and fruit consumption (average number of servings consumed per day), and meat and fish consumption (average number of servings consumed per week) were analyzed as potential confounding factors. In the current study, none of these parameters was found to have a statistically significant effect on levels of DNA damage or plasma antioxidant status either before or after treatment (data not shown). Therefore, these factors were excluded from further analyses.
Comet Assay Results. We determined the coefficient of variation of the comet assay between different experiments using a cell line (mouse embryonic fibroblasts European Cell Culture Collection No. 99072801) with a range of concentrations of sodium dichromate. These values ranged from 14.1% to 26.1% without FPG and from 14.2% to 26.3% with FPG (n = 8 experiments in duplicate). Furthermore, we have shown previously that intraindividual variability of DNA strand breaks in human WBC over an 8-to 12-month period was of a relatively small coefficient of variation (24%) either with or without treatment of cells with sodium dichromate (34) . A survey of previous studies indicates that these values compare favorably. Mean tail DNA was calculated for the population using WBC (with and without FPG incubation) without treatment (control) and after treatment with 100 Amol/L sodium dichromate for 1 hour at 37jC (Fig. 1 ). This concentration of sodium dichromate does not reduce intracellular levels of ATP or induce apoptosis within the period of incubation as assessed by the terminal deoxynucleotidyl transferase -mediated nick end labeling assay (data not shown) indicating that DNA strand breaks observed were not secondary to toxicity.
The mean background level of DNA strand breaks in untreated WBC was 6.54 F 0.16%. Background levels of DNA damage increased after FPG treatment to 13.45 F 0.52%, indicating the presence of endogenous oxidative damage. After treatment with sodium dichromate there was a 1.6-fold increase in DNA strand breaks (mean, 10.14 F 0.32%). A similar 1.5-fold increase was observed in levels of FPGsensitive sites after sodium dichromate treatment (mean, 20.01 F 0.71%). Analysis using a one-tailed paired Student's t test (both using mean and median values) showed a statistically significant increase in tail DNA after treatment with sodium dichromate using both the conventional comet assay (P < 0.0005) and the FPG-modified comet assay (P < 0.0005). In addition, treatment with FPG significantly increased tail DNA levels in both control nuclei (P < 0.0005) and nuclei from CrVI-treated cells (P < 0.0005).
Interindividual ranges of DNA strand breaks in controls measured by the conventional and FPG-modified comet assay were 4.06% to 11.97% and 6.02% to 18.48%, respectively. After dichromate treatment, the range of DNA strand breaks was 7.19% to 25.84% in the conventional comet assay and 8.79% to 34.72% in the FPG-modified comet assay. These data indicate substantial interindividual variation in levels of both background and dichromate-mediated DNA strand breaks and oxidative DNA damage (Fig. 1) . The mean level of FPGdependent oxidative damage (FPG-dependent oxidative damage was calculated by subtracting the percent tail DNA value obtained by the conventional comet assay from the percent tail DNA value obtained after inclusion of FPG) was 6.91 F 0.57%, and this was significantly increased (P < 0.001, one-tailed paired t test) to 9.87 F 0.66% after treatment with 100 Amol/L sodium dichromate for 1 hour at 37jC.
DNA Strand Breaks in Relation to Genotype. There was no statistically significant effect of any of the genotypes investigated on levels of frank DNA strand breaks as assessed by the conventional comet assay (data not shown). In addition, GSTM1, GSTT1, NQO1 (codon 187) and XRCC1 (codon 194) polymorphic genotypes had no statistically significant effect on levels of oxidative DNA damage as assessed by the FPG-modified comet assay in either controls or after treatment with sodium dichromate (summarized in Table 2 ).
Individuals were analyzed for the OGG1 Cys 326 polymorphism by PCR-RFLP (Fig. 2) (Fig. 3) . Wild-type and heterozygous individuals did not differ significantly (P = 0.639; Fig. 3) .
Interestingly, the same profile was observed when the data were analyzed as FPG-dependent oxidative DNA damage (Fig. 4) (Fig. 4) . Wildtype and heterozygous individuals did not differ significantly (P = 0.700; Fig. 4 ).
Correlation between DNA Strand Breaks and Plasma Antioxidant Capacity. To investigate possible relationships between antioxidant status and dichromate-induced DNA strand breaks, plasma antioxidant capacity was compared against levels of DNA strand breaks (measured using the FPGmodified comet assay). The mean plasma antioxidant capacity of the study population was 69.92 F 10.50%. Age, ethnicity, gender, alcohol consumption (in the previous week), cigarettes smoked per day on average, vegetable and fruit consumption (average number of servings consumed per day), and meat and fish consumption (average number of servings consumed per week) were all analyzed as potential confounding factors. None of these parameters was found to have a statistically significant effect on plasma antioxidant status in the relatively small numbers of subjects in this study (data not shown). However, a statistically significant positive correlation between levels of FPG-dependent oxidative DNA damage and antioxidant capacity significant (r = 0.253, P = 0.037) was observed. When individuals were divided based on OGG1 genotype, wild-type and heterozygous individuals continued to display a positive trend (r = 0.201 and 0.403, respectively). In contrast, Cys 326 homozygote individuals displayed a negative trend (r = À0.349; Fig. 5A ). When the data were analyzed as a ratio of oxidative DNA damage to plasma antioxidant capacity, Cys 326 /Cys 326 individuals had a statistically significant (P < 0.05, one-way ANOVA followed by Tukey test) higher tail DNA percent/antioxidant capacity ratio than either heterozygous or wild-type individuals (Fig. 5B) . There was no statistically significant difference (P > 0.05) between the Ser 326 / Ser 326 and Ser 326 /Cys 326 individuals (Fig. 5B) .
Discussion
In the current study we observed 2.9-and 3.6-fold ranges in control levels of DNA strand breaks in WBC from the study population (n = 72), as measured by the conventional and FPGmodified comet assays, respectively. Previous studies have observed similar variable levels of DNA strand break in cells from human populations in the absence of any chemical insult (42) (43) (44) . We have shown previously that intraindividual variability of DNA strand breaks over an 8-to 12-month period was of a relatively small coefficient of variation (24%) either with or without treatment of cells with sodium dichromate (34) . After treatment with sodium dichromate (100 Amol/L; 1 hour) 3.1-and 3.9-fold ranges in levels of DNA strand breaks were observed as assessed by the conventional and FPG-modified comet assay, respectively. Other potential sources of variability in response to dichromate treatment include interindividual differences in the intracellular reduction of chromium and the capacity to detoxify reactive intermediates. For example, large interindividual differences in the reduction of CrVI in plasma (55, 56) and blood (57) from human subjects and differences in chromium uptake in lymphoblastic cell lines derived from three different individuals (58) have been reported. In this study, potential differences in chromium uptake due to variability in reductive capacity of plasma will not contribute to the variability because in our experiments extracellular conditions were uniform. Variability could also be related to differences in DNA repair capacity. In support of this, Collins et al. (59) and Janssen et al. (60) have reported large interindividual differences in repair of 8-oxo-dG by human lymphocytes, although the basis of this variability has not been determined. Genetic polymorphisms may affect the level of expression, the structure, or the catalytic activity of metabolic or DNA repair enzymes (61), thereby potentially influencing individual susceptibility to sodium dichromate -induced DNA damage. Six common and potentially relevant genetic polymorphisms were considered in this study and related to levels of background and sodium dichromate -induced levels of DNA strand breaks and oxidative DNA damage. GSTM1 and GSTT1 genotype had no significant effect on levels of either background or dichromate-induced DNA suggesting that neither GSTM1 nor GSTT1 play a rate-limiting role in metabolic detoxification or activation of sodium dichromate. Alternatively compensatory mechanisms may exist to overcome GST deficiency, and this study cannot completely exclude a role for GSTM1 and T1 in the metabolic activation of CrVI. The polymorphism in NQO1 at codon 187 results in a protein with only 2% of the enzymic activity of the wild-type protein (39) . However, lack of correlation of this polymorphism with sodium dichromate -induced strand breaks suggests that NQO1 does not play a major role in the metabolic reduction of CrVI to species capable of causing either DNA strand breaks or oxidative DNA damage or in the metabolic detoxification of sodium dichromate. This finding is in agreement with a study in rat hepatocytes that showed inhibition of NQO1 had little effect on the cytotoxicity of CrVI (62) .
The gene products XRCC1 and OGG1 are involved in base excision repair of oxidative DNA damage. In this study, the polymorphism in XRCC1 at codon 194 had no significant effect on levels of DNA strand breaks or oxidative DNA damage either before or after dichromate treatment. OGG1 has been shown to be a glycosylase/AP lyase that cleaves the glycosidic bond of 8-oxo-dG preferentially at 8-oxo-dG:C base pairs (63) . The importance of OGG1 has been shown in a number of studies. For example, yeast strains containing OGG1 mutations show a spontaneous mutator phenotype, characterized by an increased frequency of G to T transversions (64) . Mice lacking functional OGG1 protein accumulate abnormal levels of 8-oxodG and have elevated spontaneous mutation frequencies in liver and kidney cells (65) (66) (67) (68) . In addition, Collins et al. (59) observed a lack of repair activity on a DNA substrate containing 8-oxo-dG by a protein extract from homozygous OGG1 knockout mouse embryonic fibroblasts in a modified version of the comet assay. In contrast, mammalian cells overexpressing OGG1 repair 8-oxo-dG more rapidly after toxic insult with oxidants (69) .
The human OGG1 gene is located on chromosome 3p25-p26 and allelic deletions of this region occur frequently in a variety of human cancers (70) and this has been associated with elevated 8-oxo-dG levels in lung tumors (40) . Analysis of the OGG1 gene in normal and tumor tissues has revealed somatic mutations and polymorphisms, such as the polymorphism at codon 326 that results in a Ser!Cys amino acid substitution in the protein (71, 72) . The latter has been associated with an increased risk of orolaryngeal (73) , lung (74) , and esophageal (75) (78) . In contrast, another study has indicated no difference in enzymic activity between the Ser 326 and Cys 326 variants of OGG1 in human peripheral blood lymphocytes (60) .
Our study, as outlined below, suggests that deficiency of the Cys 326 variant is evident only under conditions of oxidative stress. We found no statistically significant difference in the mean levels of background DNA damage between wild-type individuals and individuals with either one or two copies of the Cys 326 allele, as measured by the conventional or FPGmodified comet assay, was observed. Moreover, after dichromate treatment (100 Amol/L; 1 hour), there was no significant difference in mean levels of DNA strand breaks between the three groups as assessed by the conventional comet assay. In contrast, individuals homozygous for the Cys 326 allele had statistically significantly higher levels of DNA strand breaks after FPG incubation than either wild-type (P = 0.008) or Columns, mean of ratio (tail DNA % / antioxidant capacity) grouped according to OGG1 genotype; bars, SE. Difference between the means calculated using one-way ANOVA and Tukey test. *, P < 0.05 (significantly different).
heterozygous (P = 0.003) individuals. Furthermore, the same trend was also observed when the data were analyzed as levels of FPG-dependent oxidative damage (P = 0.02 and P = 0.01, respectively). Although this association has been shown to be statistically significant, we recognize that a relatively small number (n = 8) of Cys 326 /Cys 326 OGG1 genotype individuals have been studied and these individuals all had an antioxidant capacity above 70%. We recognize that further analyses in a larger population and a wider range of antioxidant capacities are required for confirmation of our findings. In support of our observations a similar correlation between 8-oxo-dG in leukocytes and OGG1 genotype has been made by Tarng et al. (79) (80) has reported that activity of the DNA repair protein XPA is modulated by redox modification to a zinc finger motif present in its active site. In addition, reduced repair capacity of variant OGG1 protein only under conditions of oxidative stress would explain why no difference between background levels of oxidative DNA damage was observed between the three groups. Interestingly, a reduction in activity of FPG (the functional homologue of OGG1 in Escherichia coli) has already been shown as a result of oxidation of cysteine residues in the zinc finger region (81) . In addition, OGG1 has been shown to be regulated by posttranslational phosphorylation of an unidentified serine residue apparently by protein kinase C resulting in translocation of OGG1 from the chromatin and nuclear matrix to the condensed chromatin during mitosis (82) . Ser 326 is not thought to be a constituent of a potential protein kinase C consensus sequence in OGG1. It is possible, however, that phosphorylation of Ser 326 by another kinase may also posttranslationally regulate OGG1. Substitution of Ser 326 with a cysteine residue may therefore potentially alter OGG1 activity and/or cellular location either by thiol oxidation or by avoidance of phosphorylation.
As with levels of DNA damage, large interindividual variations in levels of plasma antioxidant capacity (mean, 69.2 F 10.5%; range, 27.8-91.6%) were observed. The relationship between plasma antioxidant capacity and WBC intracellular redox status is complex. There is evidence of a positive correlation between intracellular and plasma (extracellular) levels of glutathione, ascorbate, and vitamin E (83) (84) (85) . Furthermore, intracellular levels of both glutathione and ascorbate are negatively correlated with 8-oxo-dG levels in lymphocytes (86) . In addition, plasma levels of antioxidants including ascorbate, h-carotenoids, lycopenes, and vitamin E are also negatively correlated with levels of DNA oxidation in human lymphocytes (87) (88) (89) (90) . Therefore, plasma antioxidant capacity is likely to be an indicator of WBC intracellular redox status and may be related to the ability to activate sodium dichromate within the cell by the reductive antioxidants GSH and ascorbate. In this study we Further analysis revealed that Cys 326 /Cys 326 individuals had a statistically significant (P < 0.05, one-way ANOVA followed by Tukey test) higher tail DNA percent/antioxidant capacity ratio than either heterozygous or wild-type individuals. These data suggest that Cys 326 /Cys 326 individuals have a functionally different relationship between plasma antioxidant capacity and sodium dichromate -induced oxidative DNA damage than either heterozygous or wildtype individuals. Despite the relatively low power of this study for the Cys 326 /Cys 326 genotype, the finding of a statistically significant difference between these and Ser 326 / Ser 326 individuals emphasizes the biological importance of this polymorphism in the context of responsiveness to chromium-mediated oxidative DNA damage.
Although the basis of this difference remains to be determined, we hypothesize that in wild-type and heterozygous individuals the major determinant of DNA damage by dichromate is reductive activation by GSH (as shown in Fig. 6 ), which correlates with plasma antioxidant activity. In contrast, although GSH still plays a role in sodium dichromate activation in Cys 326 /Cys 326 individuals, impaired DNA repair capacity of variant OGG1 protein under conditions of oxidative stress is proposed to become rate limiting through thiol oxidation and enzyme inactivation. Therefore, Cys 326 /Cys 326 individuals with a relatively low antioxidant (and GSH) capacity are expected to have higher levels of dichromate-induced DNA oxidation despite less activation because of lower cellular reductants. We propose that the reason why the codon 326 Cys residue in OGG1 impairs function is due to higher chances of thiol modification of this residue under conditions of high oxidative stress. As antioxidant levels increase, thiol modification becomes less prevalent and the Cys residue no longer impairs OGG1 function and therefore no difference is found between these two proteins in their ability to repair DNA damage (see Fig. 6 ). In summary, the results of this study suggest that the Cys 326 /Cys 326 OGG1 genotype is responsible for a substantial proportion of the interindividual variation in response to dichromate-induced oxidative DNA damage. We hypothesize that this is a result of reduced repair activity of variant OGG1 protein (conferred by the Cys 326 residue) under conditions of cellular oxidative stress and that the Cys 326 /Cys 326 OGG1 genotype represents a phenotype that is deficient in the repair of sodium dichromate -induced oxidative DNA damage. Consequently, OGG1 genotype is a candidate biomarker of susceptibility for CrVI-induced lung cancer in occupationally exposed individuals.
